Brand
Harbin Jixianglong Biotech
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Harbin Jixianglong Biotech and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-03-11FDA-DrugClass IIContact your pharmacy about semaglutide
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Get notified about new Harbin Jixianglong Biotech recalls
Free weekly digest. We email when a new federal recall affects Harbin Jixianglong Biotech or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state